Vierbuchen M J, Fruechtnicht W, Brackrock S, Krause K T, Zienkiewicz T J
Department of Pathology, General Hospital St. Georg, Hamburg, Germany.
Cancer. 1995 Sep 1;76(5):727-35. doi: 10.1002/1097-0142(19950901)76:5<727::aid-cncr2820760504>3.0.co;2-r.
Enhanced sialylation has been considered important for the metastatic growth of colorectal carcinomas. Using sequence- and sialic acid-specific lectins and a monoclonal antibody, the tumor-associated expression of alpha(2,3)- and alpha(2,6)-sialylated oligosaccharides was investigated. The study was designed to examine whether a random increase of sialylation or the expression of oligosaccharides carrying distinct sialic acid residues affect the biology of colorectal carcinomas.
Using computerized image analysis, formalin fixed and paraffin wax embedded specimens from 152 primary colorectal carcinomas were subjected to a quantitative analysis of the occurrence of sialoglycoconjugates detected by the maackia amurensis agglutinin (MAA: specific for alpha(2,3)-linked sialic acid residues), sambucus nigra agglutinin (SNA: specific for alpha(2,6)-linked sialic acid residues), and the monoclonal antibody B72.3 (MAB B72.3: specific for alpha(2,6)-N-acetyl-galactosamine-1-O-Ser/Thre). The data obtained by quantitating lectin/immunohistochemistry were related to morphologic and clinical parameters.
Alpha(2,3)-linked sialic acid residues increased from Stage I to Stage II tumors but decreased in advanced carcinomas. Alpha(2,6)-sialylated glycoconjugates did not show any association with local tumor growth (depth of invasion). However, metastatic tumor growth was accompanied by a significant increase of alpha(2,6)-sialylated carbohydrate sequences. Univariate survival analysis revealed that the expression of SNA- and MAB B72.3-defined reactivity displayed an inverse relation to 5-year survival. Although more advanced tumor stage was associated with poor 5-year survival, tumors below the cutoff points for SNA- and MAB B72.3-defined reactivity indicated a better prognosis than the neoplasms above the cutoff points. In contrast, the expression of alpha(2,3)-linked sialic acid residues as detected by MAA had no significant effect on survival. Multivariate regression analysis revealed that SNA-reactivity, followed by tumor stage and the MAB B72.3-defined antigen reactivity were independent prognostic variables predicting overall survival, whereas MAA-reactivity, sex, age, histologic differentiation, and tumor grade had no independent prognostic value. The simultaneous expression of both sialyl-Tn- and SNA-reactivity determined tumors of high risk patients within the different tumor stages.
Sequence-specific sialylation is associated with altered biologic behavior of colorectal carcinomas.
增强的唾液酸化作用被认为对结直肠癌的转移生长很重要。使用序列和唾液酸特异性凝集素以及单克隆抗体,研究了α(2,3)-和α(2,6)-唾液酸化寡糖的肿瘤相关表达。本研究旨在检验唾液酸化的随机增加或携带不同唾液酸残基的寡糖表达是否会影响结直肠癌的生物学特性。
采用计算机图像分析技术,对152例原发性结直肠癌的福尔马林固定石蜡包埋标本进行定量分析,检测用黑果腺肋花楸凝集素(MAA:对α(2,3)-连接的唾液酸残基具有特异性)、接骨木凝集素(SNA:对α(2,6)-连接的唾液酸残基具有特异性)以及单克隆抗体B72.3(MAB B72.3:对α(2,6)-N-乙酰半乳糖胺-1-O-丝氨酸/苏氨酸具有特异性)检测到的唾液酸糖缀合物的出现情况。通过定量凝集素/免疫组织化学获得的数据与形态学和临床参数相关。
α(2,3)-连接的唾液酸残基在I期至II期肿瘤中增加,但在晚期癌中减少。α(2,6)-唾液酸化糖缀合物与局部肿瘤生长(浸润深度)无任何关联。然而,转移性肿瘤生长伴随着α(2,6)-唾液酸化碳水化合物序列的显著增加。单因素生存分析显示,SNA和MAB B72.3定义的反应性表达与5年生存率呈负相关。尽管肿瘤分期越晚5年生存率越低,但低于SNA和MAB B72.3定义反应性临界值的肿瘤预后比高于临界值的肿瘤更好。相比之下,MAA检测到的α(2,3)-连接的唾液酸残基表达对生存率无显著影响。多因素回归分析显示,SNA反应性、其次是肿瘤分期和MAB B72.3定义的抗原反应性是预测总生存的独立预后变量,而MAA反应性、性别、年龄、组织学分化和肿瘤分级无独立预后价值。唾液酸-Tn和SNA反应性的同时表达可确定不同肿瘤分期高危患者的肿瘤。
序列特异性唾液酸化与结直肠癌生物学行为的改变相关。